ADHD Drugs and Cardiovascular Risk

Phenylpropanolamine and the Risk of Hemorrhagic Stroke

Kernan, W. N., Viscoli, C. M., Brass, L. M., Broderick, J. P., Brott, T. G., Feldmann, E. G., Morgenstern, L. B., Wilterdink, J. L., & Horwitz, R. I. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012213432501 · Cited by 746

Contraindicated Use of Cisapride

Smalley, W. E., Shatin, D., Wysowski, D. K., Gurwitz, J. H., Andrade, S. E., Goodman, M. J., Chan, K. A., Platt, R. G., Schech, S. D., & Ray, W. A. (2000) · JAMA · doi:10.1001/jama.284.23.3036 · Cited by 253

Blood Pressure Changes Associated With Medication Treatment of Adults With Attention-Deficit/Hyperactivity Disorder

Wilens, T. E., Hammerness, P. G., Biederman, J., Kwon, A., Spencer, T. J., Clark, S., Scott, M., Podolski, A., Ditterline, J., Morris, M. C., et al. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0215 · Cited by 149

Postmarketing Surveillance of Suicidal Adverse Events with Pediatric Use of Antidepressants

Mosholder, A. D., & Pamer, C. A. (2006) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.16.33 · Cited by 25

Report From the Cardiovascular and Renal Drugs Advisory Committee

Nissen, S. E. (2005) · Circulation · doi:10.1161/circulationaha.105.573105 · Cited by 20

The Relative Safety of Ephedra Compared with Other Herbal Products

Kingston, R. L., & Borron, S. W. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-5_part_1-200309020-00017 · Cited by 6

Treatment of depression in patients with congestive heart failure

Shapiro, P. A. (2009) · Heart Failure Reviews · doi:10.1007/s10741-007-9058-6 · Cited by 30

Clinical assessment and treatment of ADHD in children

Smoot, L. C., Boothby, L. A., & Gillett, R. C. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01519.x · Cited by 30

Clinical Pharmacology of Comorbid Attention Deficit Hyperactivity Disorder in Tourette Syndrome

Rizzo, R., & Gulisano, M. (2013) · International review of neurobiology · doi:10.1016/b978-0-12-411546-0.00014-7 · Cited by 30

Methylphenidate and Amphetamine Do Not Induce Cytogenetic Damage in Lymphocytes of Children With ADHD

Witt, K. L., Shelby, M. D., Itchon-Ramos, N., Faircloth, M. A., Kissling, G. E., Chrisman, A. K., Ravi, H., Murli, H., Mattison, D. R., & Kollins, S. H. (2008) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3181893620 · Cited by 29

ADHD Drugs and Cardiovascular Risk

Rappley, M. D., MOORE, J. W., & Dokken, D. L. (2006) · New England Journal of Medicine · doi:10.1056/nejmc061187 · Cited by 29

Do Stimulant Medications Improve Educational and Behavioral Outcomes for Children with ADHD?

Currie, J., Stabile, M., & Jones, L. E. (2013) · National Bureau of Economic Research · doi:10.3386/w19105 · Cited by 29

Treatment planning for children with attention-deficit/hyperactivity disorder: treatment utilization and family preferences

Brinkman, W. B., & Epstein, J. N. (2011) · Patient Preference and Adherence · doi:10.2147/ppa.s10647 · Cited by 28

The QT interval and psychotropic medications in children

McNally, P., McNicholas, F., & Oslizlok, P. C. (2006) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-006-0573-0 · Cited by 30

Neuroleptic Malignant Syndrome From Aripiprazole in an Agitated Pediatric Patient

Palakurthi, H. B., Parvin, M. M., & Kaplan, S. L. (2007) · Clinical Neuropharmacology · doi:10.1097/01.wnf.0000240941.13876.5e · Cited by 27

Development and Psychometric Properties of a Theory-Guided Prescription Stimulant Misuse Questionnaire for College Students

Bavarian, N., Flay, B. R., Ketcham, P. L., & Smit, E. (2013) · Substance Use & Misuse · doi:10.3109/10826084.2013.778283 · Cited by 26

Symptom management challenges in heart failure: pharmacotherapy considerations

Stewart, D., & McPherson, M. L. (2017) · Heart Failure Reviews · doi:10.1007/s10741-017-9632-5 · Cited by 26

Effects of long-term methylphenidate use on growth and blood pressure: results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS)

McCarthy, S., Neubert, A., Man, K. K. C., Banaschewski, T., Buitelaar, J., Carucci, S., Coghill, D., Danckaerts, M., Falissard, B., Garas, P., et al. (2018) · BMC Psychiatry · doi:10.1186/s12888-018-1884-7 · Cited by 25

Amphetamines, Atomoxetine and the Risk of Serious Cardiovascular Events in Adults

Schelleman, H., Bilker, W. B., Kimmel, S. E., Daniel, G. W., Newcomb, C. W., Guevara, J. P., Cziraky, M. J., Strom, B. L., & Hennessy, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0052991 · Cited by 25

An Exploratory Multilevel Analysis of Nonprescription Stimulant Use in a Sample of College Students

Bavarian, N., Flay, B. R., & Smit, E. (2013) · Journal of Drug Issues · doi:10.1177/0022042613491109 · Cited by 25

ADHD misdiagnosis: Causes and mitigators

Furzer, J., Dhuey, E., & Laporte, A. (2022) · Health Economics · doi:10.1002/hec.4555 · Cited by 25

Blood Pressure, Heart Rate, and CNS Stimulant Medication Use in Children with and without ADHD: Analysis of NHANES Data

Hailpern, S. M., Egan, B. M., Lewis, K. D., Wagner, C., Shattat, G. F., Qaoud, D. I. A., & Shatat, I. F. (2014) · Frontiers in Pediatrics · doi:10.3389/fped.2014.00100 · Cited by 25

Psychostimulants/Atomoxetine and Serious Cardiovascular Events in Children with ADHD or Autism Spectrum Disorder

Houghton, R., de Vries, F., & Loss, G. J. (2019) · CNS Drugs · doi:10.1007/s40263-019-00686-4 · Cited by 25

Long-Term Safety of Stimulant Medications Used to Treat Children with ADHD

Lerner, M., & Wigal, T. L. (2008) · Pediatric Annals · doi:10.3928/00904481-20080101-11 · Cited by 25

Adult Attention-Deficit/Hyperactivity Disorder Treatment and Cardiovascular Implications

Hammerness, P. G., Surman, C. B. H., & Chilton, A. (2011) · Current Psychiatry Reports · doi:10.1007/s11920-011-0213-3 · Cited by 24

An innovative SMS intervention to improve adherence to stimulants in children with ADHD: Preliminary findings

Fried, R. S., DiSalvo, M., Kelberman, C., Adler, A., McCafferty, D., Woodworth, K. Y., Green, A., Biederman, I., Faraone, S. V., & Biederman, J. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120908014 · Cited by 24

QT Interval and Dispersion in Very Young Children Treated with Antipsychotic Drugs: A Retrospective Chart Review

Nahshoni, E., Spitzer, S., Berant, M., Shoval, G., Zalsman, G., & Weizman, A. (2007) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2007.0061 · Cited by 24

The Importance of ADHD Subtype Classification for Educational Applications of DSM-V

Barnard-Brak, L. M., Stevens, T., To, Y. M., Lan, W. Y., & MULSOW, M. H. (2009) · Journal of Attention Disorders · doi:10.1177/1087054708326433 · Cited by 24

ADHD Remote Technology study of cardiometabolic risk factors and medication adherence (ART-CARMA): a multi-centre prospective cohort study protocol

Denyer, H., Ramos‐Quiroga, J. A., Folarin, A., Ramos, C., Nemeth, P., Bilbow, A., Woodward, E., Whitwell, S., Müller-Sedgwick, U., Larsson, H., et al. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-04429-6 · Cited by 22

A young man with acute dilated cardiomyopathy associated with methylphenidate

Nymark, T.-B. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s2410 · Cited by 23

Safety and tolerability of flexible dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder

Challis (2009) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s6873 · Cited by 23

Cardiovascular Effects of Psychotropic Drugs

Kovacs, D., & Arora, R. (2008) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e31802e4b9f · Cited by 23

Treatment patterns among adults with attention-deficit/hyperactivity disorder in the United States: a retrospective claims study

Schein, J. R., Childress, A. C., Adams, J., Cloutier, M., Gagnon‐Sanschagrin, P., Maitland, J., Bungay, R., Guérin, A., & Lefèbvre, P. (2021) · Current Medical Research and Opinion · doi:10.1080/03007995.2021.1968814 · Cited by 22

How to Predict the Impact of Methylphenidate on Cardiovascular Risk in Children with Attention Deficit Disorder: Methylphenidate Improves Autonomic Dysfunction in Children with ADHD

Buchhorn, R., Müller, C., Willaschek, C., & Norozi, K. (2012) · ISRN Pharmacology · doi:10.5402/2012/170935 · Cited by 22

The Cochrane Collaboration withdraws a review on methylphenidate for adults with attention deficit hyperactivity disorder

Boesen, K., Saiz, L. C., Erviti, J., Storebø, O. J., Gluud, C. N., Gøtzsche, P. C., & Jørgensen, K. J. (2017) · BMJ Evidence-Based Medicine · doi:10.1136/ebmed-2017-110716 · Cited by 22

Impact of the American Heart Association Scientific Statement on Screening Electrocardiograms and Stimulant Medications

Thomas, P. E., Carlo, W. F., Decker, J. A., Cannon, B. C., Kertesz, N. J., Friedman, R. A., & Kim, J. (2011) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpediatrics.2010.278 · Cited by 22

Cardiovascular Safety of Stimulant Medications for Pediatric Attention-Deficit Hyperactivity Disorder

Silva, R. R., Skimming, J. W., & Muniz, R. (2010) · Clinical Pediatrics · doi:10.1177/0009922810368289 · Cited by 22

Cardiovascular Effects of Drugs Used to Treat Attention-Deficit/Hyperactivity Disorder Part 2

Fay, T. B., & Alpert, M. (2018) · Cardiology in Review · doi:10.1097/crd.0000000000000234 · Cited by 22

Pharmacologic Intervention for Attention-Deficit Hyperactivity Disorder in Preschoolers: Is It Justified?

Ghuman, J. K., & Ghuman, H. S. (2013) · Pediatric Drugs · doi:10.1007/s40272-012-0001-5 · Cited by 21

Stimulants and Pediatric Cardiovascular Risk

ZITO, J. M., & Burcu, M. (2016) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2015.0239 · Cited by 21

Medication options when treating children and adolescents with ADHD: interpreting the NICE guidance 2006: Figure 1

Harpin, V. (2008) · Archives of Disease in Childhood Education & Practice · doi:10.1136/adc.2006.106864 · Cited by 21

Baseline values from the electrocardiograms of children and adolescents with ADHD

Prasad, S., Furr, A. J., Zhang, S., Ball, S. G., & Allen, A. J. (2007) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/1753-2000-1-11 · Cited by 21

Stimulant Treatment of ADHD and Risk of Sudden Death in Children

Vitiello, B., & Towbin, K. E. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09050619 · Cited by 21

An inventory of European data sources for the long-term safety evaluation of methylphenidate

Murray, M. L., Insuk, S., Banaschewski, T., Neubert, A. C., McCarthy, S., Buitelaar, J. K., Coghill, D., Dittmann, R. W., Konrad, K., Panei, P., et al. (2013) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-013-0386-x · Cited by 20

Pre‐existing cardiovascular conditions and pharmacological treatment of adult ADHD

Gerhard, T., Winterstein, A. G., Olfson, M., Huang, C., Saidi, A. S., & Crystal, S. (2010) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1931 · Cited by 21

Adding methylphenidate to prism-adaptation improves outcome in neglect patients. A randomized clinical trial

Luauté, J., Villeneuve, L., Roux, A. S., Nash, S., Bar, J.-Y., Chabanat, E., Cotton, F., Ciancia, S., Sancho, P. O., Hovantruc, P., et al. (2018) · Cortex · doi:10.1016/j.cortex.2018.03.028 · Cited by 22

Long-Term Safety of Stimulant Medications Used to Treat Children with ADHD

Lerner, M., & Wigal, T. L. (2008) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20080801-06 · Cited by 20

Attention Deficit Hyperactivity Disorder in Children: Comparative Efficacy of Traditional Chinese Medicine and Methylphenidate

Lan, Y., Zhang, L.-L., & Luo, R. (2009) · Journal of International Medical Research · doi:10.1177/147323000903700340 · Cited by 19

Stimulant therapy in children with attention-deficit/hyperactivity disorder and concomitant long QT syndrome: A safe combination?

Rohatgi, R. K., Bos, J. M., & Ackerman, M. J. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.04.043 · Cited by 19

A Case of Acute Cardiomyopathy and Pericarditis Associated with Methylphenidate

Dadfarmay, S., & Dixon, J. (2009) · Cardiovascular Toxicology · doi:10.1007/s12012-009-9033-7 · Cited by 19

Changes and Challenges: Managing ADHD in a Fast-Paced World

Manos, M. J., Tom-Revzon, C., Bukstein, O. G., & Crismon, M. L. (2007) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2007.13.9-b.1 · Cited by 18

Cardiovascular Safety of Stimulants in Children: Findings from Recent Population-Based Cohort Studies

Winterstein, A. G. (2013) · Current Psychiatry Reports · doi:10.1007/s11920-013-0379-y · Cited by 18

Sociocultural Issues in African American and Hispanic Minorities Seeking Care for Attention-Deficit/Hyperactivity Disorder

Bailey, R. K., Jaquez-Gutierrez, M. C., & Madhoo, M. (2014) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.14r01627 · Cited by 22

Addressing the problem of ADHD medication as neuroenhancements

Graf, W. D., Miller, G., & Nagel, S. K. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.908707 · Cited by 19

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

assessment, I. A. M. H., (inattention, T. C. S. S. F. A. B. S. A. Q. R. T. M. S. D. O. A., impulsivity, the, A. H. A. A. W. S. S. C. I. T. S. Q. S. B. A. R. O. T. N. O. T. C. C. R. S. O. S. Q. C., symptoms of ADHD can also be included in clinic/office registration materials to be completed by parents before visits or in the waiting room before the evaluation. If a parent reports that the patient suffers from any symptoms of ADHD that induce impairment or if the patient scores in the clinical range for ADHD symptoms on a rating scale, & indicated., T. A. F. E. F. A. A. S. O. I. T. N. R. I. (2008) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.6.3.foc401 · Cited by 18

Ephedra alkaloids inhibit platelet aggregation

Watson, R., Woodman, R., & Lockette, W. E. (2010) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e328337b39f · Cited by 17

Improving Postapproval Drug Safety Surveillance: Getting Better Information Sooner

Hennessy, S., & Strom, B. L. (2014) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-135955 · Cited by 17

Pulmonary Aterial Hypertension in an Adolescent Treated with Methylphenidate

Karaman, M. G., Atalay, F., Tufan, A. E., & Erdoğan, A. (2010) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2009.0095 · Cited by 16

Drug Prescriptions for Children With ADHD in Japan: A Study Based on Health Insurance Claims Data Between 2005 and 2015

Yoshida, M., Obara, T., Kikuchi, S., Satoh, M., Morikawa, Y., Ooba, N., Yamaguchi, H., & Mano, N. (2019) · Journal of Attention Disorders · doi:10.1177/1087054719843179 · Cited by 16

Cardiovascular Risk Screening Before Starting Stimulant Medications and Prescribing Practices of Canadian Physicians: Impact of the Health Canada Advisory

Conway, J. L., Wong, K. K., O’Connell, C. M., & Warren, A. E. (2008) · PEDIATRICS · doi:10.1542/peds.2008-0276 · Cited by 16

Attention deficit hyperactivity disorder medications in children with heart disease

Berger, S. (2016) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000388 · Cited by 16

Acute effect of methylphenidate on QT interval duration and dispersion in children with attention deficit hyperactivity disorder

İlgenli, T. F., Cöngöloğlu, M. A., Öztürk, C., Türkbay, T., Akpınar, O., & Kılıçaslan, F. (2007) · Advances in Therapy · doi:10.1007/bf02850007 · Cited by 16

The Risk of Methylphenidate Pharmacotherapy for Adults with ADHD

Bieś, R., Fojcik, J., Warchala, A., Trędzbor, B., Krysta, K., Piekarska-Bugiel, K., & Krzystanek, M. (2023) · Pharmaceuticals · doi:10.3390/ph16091292 · Cited by 16

Cardiovascular safety of ADHD medications: rationale for and design of an investigator‐initiated observational study

Hennessy, S., Schelleman, H., Daniel, G. W., Bilker, W. B., Kimmel, S. E., Guevara, J. P., Cziraky, M. J., & Strom, B. L. (2010) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1992 · Cited by 15

Early Repolarization in Young Children with Attention-Deficit/Hyperactivity Disorder Versus Normal Controls: A Retrospective Preliminary Chart Review Study

Nahshoni, E., Sclarovsky, S., Spitzer, S., Zalsman, G., Strasberg, B., & Weizman, A. (2009) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2009.0034 · Cited by 15

Examining Parental Nonresponse to Stimulant Treatment Questions According to Ethnicity

Barnard-Brak, L. M., & To, Y. M. (2009) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2008.0150 · Cited by 15

Population Pharmacokinetics of Methylphenidate in Healthy Adults Emphasizing Novel and Known Effects of Several Carboxylesterase 1 (CES1) Variants

Lyauk, Y. K., Stage, C., Bergmann, T. K., Ferrero‐Miliani, L., Bjerre, D., Thomsen, R., Dalhoff, K., Rasmussen, H., & Jűrgens, G. (2016) · Clinical and Translational Science · doi:10.1111/cts.12423 · Cited by 15

Cardiac Arrest with Pulseless Electrical Activity Associated with Methylphenidate in an Adolescent with Normal Baseline Echocardiogram

Daly, M. W., Custer, G., & McLeay, P. D. (2008) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.11.1408 · Cited by 15

Prediction of Carboxylesterase 1-mediated In Vivo Drug Interaction between Methylphenidate and Cannabinoids using Static and Physiologically Based Pharmacokinetic Models

Qian, Y., & Markowitz, J. S. (2022) · Drug Metabolism and Disposition · doi:10.1124/dmd.121.000823 · Cited by 14

Liver Transplant in a Patient under Methylphenidate Therapy: A Case Report and Review of the Literature

Tong, H. Y., Díaz, C., Collantes, E., Medrano, N., Borobia, A. M., Jara, P., & Ramı́rez, E. (2015) · Case Reports in Pediatrics · doi:10.1155/2015/437298 · Cited by 13

ADHD Drugs and Serious Cardiovascular Events in Children and Young Adults

Kevill, J. W. (2012) · Yearbook of Neurology and Neurosurgery · doi:10.1016/j.yneu.2012.05.075 · Cited by 13

Update on adult attention-deficit/hyperactivity disorder

Hammerness, P. G., Surman, C. B. H., & Miller, K. (2008) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-008-0077-z · Cited by 12

Nutritional Intervention in ADHD

Newmark, S. C. (2009) · EXPLORE · doi:10.1016/j.explore.2009.03.006 · Cited by 12

Addressing Dual Diagnosis Patients Suffering from Attention-Deficit Hyperactivity Disorders and Comorbid Substance Use Disorders

Martínez-Raga, J., Knecht, C., de Alvaro, R., Szerman, N., & Ruiz, P. (2012) · Addictive Disorders & Their Treatment · doi:10.1097/adt.0b013e318277060c · Cited by 12

Hemodynamic and Cardiac Neurotransmitter-releasing Effects in Conscious Dogs of Attention- and Wake-promoting Agents: A Comparison of d-Amphetamine, Atomoxetine, Modafinil, and a Novel Quinazolinone H3 Inverse Agonist

Lynch, J. J., Regan, C. P., Stump, G. L., Tannenbaum, P. L., Stevens, J., Bone, A., Gilberto, D. B., Johnson, C. A., Fujino, N., Takenaga, N., et al. (2009) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318195a470 · Cited by 11

Adverse drug event‐related hospitalisation in persons with neurodevelopmental disorders: a state‐wide retrospective cohort study

Zhou, M., Du, W., Salvador‐Carulla, L., & Glasgow, N. (2019) · Journal of Intellectual Disability Research · doi:10.1111/jir.12586 · Cited by 11

Pharmacotherapy of ADHD in adults

Prince, J. B., Morrison, N. R., & Wilens, T. E. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139035491.023 · Cited by 11

Assessment of potential cardiovascular risks of methylphenidate in comparison with sibutramine: do we need a SCOUT (trial)?

Antel, J., Albayrak, Ö., Heusch, G., Banaschewski, T., & Hebebrand, J. (2014) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-014-0522-8 · Cited by 11

Pharmacologic treatment of ADHD: road conditions in driving patients to successful outcomes.

Manos, M. J. (2008) · PubMed Central · Cited by 11

A comparative review of “how to” books for parents of ADHD children and “how to” books for parents of typical children

Pajo, B., & Stuart, P. H. (2012) · Children and Youth Services Review · doi:10.1016/j.childyouth.2012.01.011 · Cited by 11

Special Considerations in Diagnosing and Treating Attention-Deficit/Hyperactivity Disorder

Wigal, S. B., & Wigal, T. L. (2007) · CNS Spectrums · doi:10.1017/s1092852900026092 · Cited by 11

Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults

Boesen, K., Danborg, P. B., Gøtzsche, P. C., & Jørgensen, K. J. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012857 · Cited by 11

Pharmacologic Management of Excessive Daytime Sleepiness

Takenoshita, S., & Nishino, S. (2020) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2020.02.006 · Cited by 11

Cardiovascular System

Greaves, P. (2007) · Elsevier eBooks · doi:10.1016/b978-044452771-4/50008-0 · Cited by 10

Pediatric and Adolescent Psychopharmacology: A Practical Manual for Pediatricians

Greydanus, D. E., Calles, J. L., & Patel, D. R. (2008) · Cited by 10

Hypokalemic Sensory Overstimulation

Segal, M. M., Rogers, G. F., Needleman, H. L., & Chapman, C. A. (2007) · Journal of Child Neurology · doi:10.1177/0883073807307095 · Cited by 9

Exercise outcomes in prevalent users of stimulant medications

Westover, A. N., Nakonezny, P. A., Barlow, C. E., Vongpatanasin, W., Adinoff, B. H., Brown, E. S., Mortensen, E. M., Halm, E. A., & DeFina, L. F. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.03.011 · Cited by 9

Adderall and cardiovascular risk: A therapeutic dilemma

Sichilima, T., & Rieder, M. J. (2009) · Paediatrics & Child Health · doi:10.1093/pch/14.3.193 · Cited by 9

Beyond ADHD and narcolepsy: psychostimulants in general psychiatry

Ng, B., & O'Brien, A. (2009) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.107.004879 · Cited by 14

The Chiropractic Care of Children With Attention-Deficit/Hyperactivity Disorder: A Retrospective Case Series

Alcantara, J., & Davis, J. (2010) · EXPLORE · doi:10.1016/j.explore.2010.02.001 · Cited by 9

Cardiovascular Nursing Disease in the Young Congenital Cardiac Defects Committee and the Council on Statement From the American Heart Association Council on Cardiovascular Receiving Medications for Attention Deficit/Hyperactivity Disorder : A Scientific Cardiovascular Monitoring of Children and Adolescents With Heart Disease

Uzark, K. C., Webb, C. L., Vetter, V. L., Elia, J., Erickson, C., Berger, S., & Blum, N. J. (2011) · Cited by 9

A randomized controlled laboratory study on the long-term effects of methylphenidate on cardiovascular function and structure in rhesus monkeys

Wilkinson, J. D., Callicott, R. J., Salminen, W. F., Sandhu, S., Greenhaw, J. J., Paredes, A. M., Davis, K. J., Jones, E. Y., Paule, M. G., Slikker, W., et al. (2018) · Pediatric Research · doi:10.1038/s41390-018-0256-9 · Cited by 9

The Last Normal Child: Essays on the Intersection of Kids, Culture, and Psychiatric Drugs

Carson, N. J. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31815896c7 · Cited by 9

Setting the Public Agenda

Moffitt, S. L. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107588141.007 · Cited by 8

Effects of methylphenidate on blood pressure, QT-interval, and cardiac output in ADHD diagnosed children: A three months’ follow-up study

Omidi, N., Ghorashi, S. M., Tajrishi, F. Z., Effatpanah, M., Khatami, F., & Khorgami, M. (2021) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2021.100805 · Cited by 8

Diurnal changes in blood pressure and heart rate in children with narcolepsy with cataplexy

Wang, J., Yan, Z., Dong, X., Li, J., Zhao, L., Zhang, X., Lv, C., Zhao, Z., Strohl, K. P., & Han, F. (2022) · Journal of Sleep Research · doi:10.1111/jsr.13736 · Cited by 8

Amphetamine Containing Dietary Supplements and Acute Myocardial Infarction

Perez-Downes, J. C., Hritani, A., Baldeo, C., & Antoun, P. S. (2016) · Case Reports in Cardiology · doi:10.1155/2016/6404856 · Cited by 8

Cardiovascular System

Greaves, P. (2012) · Elsevier eBooks · doi:10.1016/b978-0-444-53856-7.00007-5 · Cited by 8

Treatment of hyperactive children: Increased efficiency through modifications of homeopathic diagnostic procedure

Laing, R. (2006) · Homeopathy · doi:10.1016/j.homp.2006.05.003 · Cited by 8

Social Deprivation or Brain Dysfunction? Data and the Discourse of ADHD in Britain and North America

Hart, N., & Benassaya, L. (2009) · doi:10.1007/978-1-137-02058-1_9 · Cited by 7

El tratamiento del niño y adolescente con TDAH en Atención Primaria desde el punto de vista de la evidencia

Espinosa, A. L. (2006) · Hispana · Cited by 7

Cardiovascular Safety of Concomitant Use of Atypical Antipsychotics and Long-Acting Stimulants in Children and Adolescents With ADHD

Bali, V., Kamble, P., & Aparasu, R. R. (2015) · Journal of Attention Disorders · doi:10.1177/1087054715608443 · Cited by 7

Attention Deficit Hyperactivity Disorder Screening Electrocardiograms: A Community-Based Perspective

Shahani, S. A., Evans, W. N., Mayman, G. A., & Thomas, V. C. (2013) · Pediatric Cardiology · doi:10.1007/s00246-013-0810-5 · Cited by 7

Diversion and misuse of pharmaceutical stimulants among illicit drug users

Kaye, S. S., Darke, S. G., & Torok, M. H. (2013) · Addiction Research & Theory · doi:10.3109/16066359.2013.779677 · Cited by 7

Drug treatments for attention-deficit hyperactivity disorder in young people

Bates, G. D. L. (2009) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.108.005561 · Cited by 7

FDA panel recommends black box warning on ADHD stimulant medications

Gorman, R. L. (2006) · AAP News · doi:10.1542/27.4.16 · Cited by 4

FDA ponders cardiovascular risks of ADHD drugs

Young, D. (2006) · American Journal of Health-System Pharmacy · doi:10.2146/news050058 · Cited by 2

ADHD drugs should carry warning, FDA committee recommends

Tanne, J. H. (2006) · BMJ · doi:10.1136/bmj.332.7544.748-c · Cited by 1

FDA Panel Wants Warnings On ADHD Medications

Rosack, J. (2006) · Psychiatric News · doi:10.1176/pn.41.5.0001 · Cited by 1

Perspective The NEW ENGLAND JOURNAL of MEDICINE

(2006)